So, a pregnant lady walks into your office …
That’s not the opening line to a joke, but it could be the beginning of a conundrum.
By Karen Auge, Contributing Editor
Pregnancy alone should not prompt a woman’s visit to an ophthalmologist beyond the routine annual checkup. But, changes in hormones, blood flow and even fluid retention that accompany pregnancy can cause several ocular changes. Some are normal and benign, but some are not. For ophthalmologists the trick is identifying which is which, and knowing how to safely treat them.
Physicians should consider the following when treating these patients’ ocular problems.
Avoid changes if possible
It’s generally not a good idea to do LASIK procedures on a pregnant woman, or to modify an eyeglass or contact lens prescription for minor vision changes, says Natasha Herz, MD. That’s because fluid retention can cause refractive changes, but those usually resolve after the pregnancy, says Dr. Herz, clinical spokesperson for the American Academy of Ophthalmology. Of course, if the vision changes are so extreme that they put the woman in danger when she drives, then new eyeglasses would be in order, she says.
In addition, women on medication for ocular hypertension who stop taking that medication during pregnancy should be closely monitored, says Ingrid U. Scott, MD, MPH, professor of ophthalmology and public health at Penn State University College of Medicine. Dr. Scott says that the second half of pregnancy is associated with decreased IOP. Among patients with ocular hypertension, the IOP decrease that often accompanies pregnancy may be even greater. IOP changes typically return to pre-pregnancy levels approximately two months post-delivery, she says.
Common ocular issues
The vast majority of ocular symptoms that occur during pregnancy can annoy patients but are not cause for alarm. Dr. Herz says most of the concerns of pregnant women who come to her Maryland practice involve changes in vision. Many women experience dry eyes or new or worsened contact-lens intolerance. Most of the time, these conditions resolve once the pregnancy ends.
While pregnancy itself should not trigger additional monitoring by ophthalmologists, women with uncontrolled hypertension or pre-pregnancy diabetes are exceptions, says Kathleen Digre, MD, professor of neurology and ophthalmology at the University of Utah. The AAO guidelines recommend that if possible, women with diabetes undergo a dilated funduscopic eye exam before becoming pregnant, in order to establish baseline retinopathy, says Dr. Scott.
Diagnosis
Often, relatively minor conditions share symptoms with much more serious concerns. “Women often report seeing spots on the eye — that can indicate pre-eclampsia, but it can also be a symptom of migraine,” says Dr. Digre, a specialist in neuro-ophthalmology and headache. “So it’s important to check blood pressure.”
That overlap of symptoms requires careful testing and diagnosis. “The message I take to every group I speak to is: get the right diagnosis. Use whatever test you need to use to make the right diagnosis,” Dr. Digre says.
ROP screening: High legal risk and low reimbursement
Retinopathy of prematurity (ROP) is a major cause of blindness in children age 5 and under, and the leading cause of blindness among premature babies in developed countries.2,3 It is also, for the most part, preventable. But, unfortunately, the condition is probably not feared enough among parents, and physicians fear its diagnostic test too much.
Darius Moshfeghi, MD, professor of ophthalmology at Stanford University, would like to change both of these preconceptions. Primarily, he’s dedicated to convincing physicians that diagnostic testing and interpretation for ROP are not as scary as many believe. Moreover, for certain premature babies, the test is imperative.
Of the 28,000 babies born weighing less than 2.75 pounds in the United States every year:
• About 14,000 to 16,000 have some degree of ROP, according to the National Institutes of Health
• 90% are mild and don’t require treatment
• Each year some 1,000 to 1,500 infants with severe ROP are at risk for retinal detachment.
The most common intervention, laser ablation, requires general anesthesia and carries the attendant risks of any invasive procedure. But, it also has a very good chance of preventing vision loss. As many as 400 to 600 babies become legally blind in the United States each year due to ROP.4
Those children who lost their sight “either got treatment that was not good enough, or never got any treatment,” Dr. Moshfeghi says. “In a large percentage of those cases, the babies were never looked at.”
This can occur for many reasons. Parents of babies born far from urban centers may have difficulty arranging for their child to be seen by a qualified ophthalmologist. And, when a new mother takes a premature baby home, she typically takes with her a bundle of referrals for follow-up care and specialists. Overwhelmed, sleepless, stressed parents may have to prioritize doctor visits. “And which one are you not going to go to? You’re not going to the eye doctor,” says Dr. Moshfeghi, because they don’t understand the risk ROP carries. Since ROP can be progressive, many parents don’t fully comprehend the need for follow-up screenings even after an initial screening was performed in the hospital.
Other complications
ROP infants often grow up to be children and adults with eye problems. These include:
• Retinal detachment
• Amblyopia
• Strabismus
• Glaucoma3
Also, physicians believe they face risk by performing the ROP screening, which involves dilating the premature infant’s pupils, and then, most crucially, interpreting the resulting digital images correctly.
“It’s very high legal risk and very low reimbursement,” Dr. Moshfeghi says. The procedure and its interpretation are among the riskiest procedures an ophthalmologist can perform in terms of liability, he adds. Although successful liability claims are rare, when they do occur, the damage awards can reach seven figures, Moshfeghi said. And the risk continues for decades.If a child suffers vision loss, most states allow a child the opportunity to sue for up to three years after they reach adulthood.
Nevertheless, Dr. Moshfeghi, the founder of the Stanford University Network for the Diagnosis of Retinopathy of Prematurity, has made it a personal crusade to convince more ophthalmologists to perform the screening.
That crusade hasn’t always made him popular. “In the beginning, I would get up on stage and practically get pelted with tomatoes. Everyone believed [the screening] had to be done by experts. And what did they base that on? Nothing.” He says there are no data indicating that greater success in correctly diagnosing severe ROP depends on specific, advanced training.
In a 2013 position paper, the American Academy of Pediatrics recommended that the diagnosing ophthalmologist should have “sufficient knowledge and experience to identify accurately the location and sequential changes of ROP.”5
Parameters for which babies should be tested were established decades ago: those born at less than 1500 grams and those born at 30 weeks or less gestation.
Broader training is one part of the answer, and telemedicine, likewise, can be a solution both for physicians in remote or rural locations and parents who lack transportation, says Dr. Moshfeghi, who acknowledges that he has a financial interest in a company that produces cameras used in telemedicine. But, he says, he is involved in that venture because he believes it is crucial for solving a serious and fixable problem. “If you send me to look at a baby at the bedside, it is what I say it is,” Dr. Moshfeghi said. But with telemedicine, more than one pair of eyes can interpret the images and weigh in on whether ROP is present, and if so, how severe it is.
“The cost of blindness is huge,” Dr. Moshfeghi said. “It’s just not acceptable for a baby not to be looked at.”
Some routine diagnostic procedures might give physicians pause when the patient is expecting. But most procedures are safe. And, any risk associated with a procedure has to be weighed against the risk to both mother and child of making an incorrect diagnosis, Dr. Digre says. “You’ve got to find out what’s going on,” and communicate openly and often with the patient’s obstetrician.
Rare but noteworthy
Ophthalmologists should be on the lookout for other more serious conditions associated with pregnancy, says Dr. Digre. For example, pituitary edemas could enlarge during pregnancy because of hormonal changes, says Dr. Scott.
Pre-eclampsia and eclampsia, potentially serious conditions that occur in roughly 3% to 5% of pregnant women, can cause a number of ocular complications, according to a 2013 article in the Saudi Journal of Ophthalmology.1 Roughly 25% of women with severe pre-eclampsia report vision symptoms. Among women with eclampsia, the number jumps to 50%. Those symptoms include blurred vision, focal or generalized arteriolar narrowing, cotton wool spots, Elschnig spots and, in rare cases, retinal detachment.
Yet another potential complication for pregnant women is central serous chorioretinopathy (CSCR). This typically occurs more frequently in men, “but in women the condition may be associated with pregnancy,” Dr. Scott says. Patients with CSCR generally complain of reduced visual acuity and may exhibit metamorphopsia. In most cases, the condition will resolve itself without treatment a few months after delivery, she says.
In addition, idiopathic intracranial hypertension, (IIH) which is associated with females and with weight gain, can cause papilledema during pregnancy. Ordinarily, a recommended treatment for IIH is weight loss, but that is hardly practical or advisable for pregnant women, Dr. Herz says. The common drug therapy, acetazolamide, (Diamox, Duramed) is a category C medication, and therefore not advisable for pregnant women. That leaves close monitoring in cooperation with the patient’s obstetrician as the best course of action, Dr. Herz says.
Treatment options
Physicians may be understandably reluctant to prescribe medications and interventions to pregnant women that are otherwise used commonly and successfully. Caution is always the wise course, but many medications can be used safely, Dr. Digre says. Still, consult the FDA’s drug classification system and the patient’s obstetrician, she says.
Pregnancy and the eye
Pregnancy affects the eye, and complications are not uncommon.
Pathologic changes can be divided up as follows:
1. The changes occur for the first time during the pregnancy
2. The pregnancy alters an ocular pathology already in existence
3. Complications of systemic diseases. Either pregnancy-specific, such as pre-eclampsia, or those that appear more often during pregnancy, such as Graves’ disease.1
Fortunately, eye drops are almost always safe to use. These are particularly helpful in treating dry eye, which doesn’t, like many other conditions, necessarily resolve itself after the pregnancy, Dr. Herz says. In fact, it can briefly get worse due to post-pregnancy hormonal surges and lack of sleep.
Keep in mind that pregnant women may feel they have plenty to worry about, and ophthalmologists don’t want to needlessly contribute to stress, says Dr. Scott. “There is a balance. You want people to be vigilant, but you don’t want to create undue anxiety.” OM
REFERENCES
1. Khawla Abu Samra, KA. The eye and visual system in the preeclampsia/eclampsia syndrome: What to expect? Saudi J Ophthalmol. 2013 Jan; 27: 51–53.
2. Leonard, R., Gordon, A. Statistics on Vision Impairment: A Resource Manual. April 2002. Research Institute, Lighthouse Guild*
3. Retinopathy of Prematurity. International Agency for the Prevention of Blindness. Accessed Feb 12, 2016. http://www.iapb.org/knowledge/what-is-avoidable-blindness/retinopathy-prematurity.
4. Facts About Retinopathy of Prematurity. National Institutes of Health. Accessed Feb. 16, 2016. https://nei.nih.gov/health/rop/rop.
5. Fierson WM. Screening examination of premature infants for retinopathy of prematurity. 2013;131:189-195.
*Formerly Lighthouse International.